What's in the report
A 15-25 page bespoke PDF organized around your specific Matcher shortlist. Each of your top 5 distributors gets ~3 pages of analysis covering:
1
Portfolio analysis
What competing or adjacent brands the distributor currently carries — flagging direct competitive conflict with your product.
2
Capacity assessment
Estimated headcount, geographic coverage, hospital tender capability, current portfolio breadth — can they realistically add another brand?
3
Recent M&A and partnerships
Last 24 months of corporate activity — acquisitions, ownership changes, new exclusive distribution agreements. Indicates whether they're consolidating or expanding portfolio.
4
Procurement framework status
Which national / regional public procurement frameworks they hold (NHS Supply Chain tower, CONSIP, SKL Kommentus, UGAP, etc.) — critical for hospital-channel products.
5
Reference contact recommendations
2-3 named non-competing manufacturers who've worked with this distributor — for you to call directly. We don't broker the call; we tell you who to ask.
6
Editorial commentary from Miguel
Operator-grade observations from 9 years European MedTech. What this distributor is good at, what they're not, what to negotiate for in your contract.
Sample page — what one distributor entry looks like
3. Bernas Medical (France) — Verified Independent · Capital Equipment + Diagnostic Imaging · Paris HQ
Portfolio (current): Multi-brand distribution under exclusive France-wide agreements for premium imaging accessories (Sectra, Mevis, Visus), gastro endoscopy specialty lines (Pentax adjacent). Some overlap with ELSA brands in cardiothoracic surgical instruments — would need verification with Bernas BD that {your product} doesn't conflict with the {existing competitor brand} portfolio. 65 years operating; family ownership.
Capacity: ~45 FTE across France with regional coverage Paris, Lyon, Marseille, Lille. Hospital tender capability strong — won 7 of last 12 monitored UGAP framework lots in imaging accessories. Belgian extension via subsidiary covering Wallonia.
Recent activity (24mo): No public M&A activity. Renewed exclusive France agreement with Sectra in March 2025. Hired 3 KAMs in 2024 (signals capacity for new lines).
Reference contacts: Recommend reaching out to [Manufacturer X] (your direct competitor in adjacent segment — they have visibility into Bernas's commercial intensity) and [Manufacturer Y] (non-competing — works with Bernas in different vertical). Names provided in delivered PDF.
Miguel's commentary: Bernas is one of the cleanest French independent distributors I know — small, focused, hospital-tender-capable, technical-service-oriented. For your Class IIb {product type}, this is a strong candidate IF you can secure exclusivity on your sub-segment. The Sectra exclusive shows they value brand-by-brand exclusivity — likely will ask for similar from you. Negotiate exclusivity period < 24 months Year 1, performance-tied extension.
How it works
The Premium Match Report is generated after you've already used the free Matcher. The workflow:
Day 0
You order
Pay €299 via Stripe. Stripe receipt sent. We're notified.
Day 0
We email you
Within 4 hours we email asking for your Matcher inputs (sector, target countries, MDR class, channel) + your product details if you want to share.
Day 1-3
Miguel writes the report
Custom research per distributor. Sources: company sites, trade associations, procurement frameworks, M&A databases, Miguel's network. ~2-3 hours per distributor.
Day 4-5
Quality review + delivery
Final edit pass. PDF delivered to your email. Includes 30-day window for 1 follow-up Q&A round.
MB
Why this isn't just a fancy Matcher dump
The Matcher's free output is good but generic — it tells you who fits your filter. The Premium Match Report tells you what each of those distributors is actually like to negotiate with, what their portfolio gaps are, and which non-competing manufacturers you should call as references. That second layer comes from operator knowledge — 9 years sitting in the seat where these distributors call you, where you call other manufacturers about distributor reputations, and where the actual contract negotiation happens. The Matcher can't compute that. I can write it.
Country Manager · EMS Dental Portugal Affiliate. Run 6 distributor agreements personally. Filed 25+ tender responses. Sent annually to teach the EMS playbook in South Korea + Greece.
FAQ
What if I haven't run the Matcher yet?
Run it first (free, 2 minutes). Then order the Premium Report. We use your Matcher shortlist as input — without it, we'd have to ask the same 6 questions and run the Matcher for you anyway.
What if I want analysis on more than 5 distributors?
Standard report covers your top 5. For top 10 or 15, talk to us for custom scope (typically €499-€799). Email miguel@fractio.se.
Is the report based on public data?
The portfolio analysis, M&A summary, procurement framework status, and capacity assessment are based on public sources. The reference contact recommendations + Miguel's editorial commentary are based on his industry network — not anything confidential, but the kind of context that isn't on any website.
Can I share the report with my team?
Yes. The report has a single-company license — you can share within your manufacturer organization (employees, advisors, board). You cannot resell or redistribute publicly.
What's the difference between this and the Custom Intelligence Brief (€1.5-3K)?
The Premium Match Report is a fixed-scope deep-dive on your existing Matcher shortlist. The Custom Intelligence Brief is fully bespoke — competitive landscape, distributor mapping, reimbursement assessment, recommended GTM sequence — for situations where you don't yet have a shortlist or want a holistic market entry view.
Is there a refund policy?
If we cannot deliver the report within 7 working days (vs the 5-day target), we issue a full refund. Otherwise, the work is custom — no refunds after PDF delivery.
Will you tell distributors I ordered a report about them?
No. The report is confidential between us and the buyer. We don't notify distributors that they're being analyzed. We also don't take commission if you engage them.